Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Return on Capital Employed (2016 - 2022)

Edesa Biotech's Return on Capital Employed history spans 8 years, with the latest figure at 1.58% for Q2 2022.

  • For Q2 2022, Return on Capital Employed fell 43.0% year-over-year to 1.58%; the TTM value through Jun 2022 reached 1.58%, down 43.0%, while the annual FY2021 figure was 2.11%, 145.0% down from the prior year.
  • Return on Capital Employed for Q2 2022 was 1.58% at Edesa Biotech, up from 1.63% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.4% in Q3 2018 and bottomed at 2.24% in Q4 2021.
  • The 5-year median for Return on Capital Employed is 1.0% (2018), against an average of 1.03%.
  • The largest annual shift saw Return on Capital Employed surged 45bps in 2019 before it plummeted -120bps in 2021.
  • A 5-year view of Return on Capital Employed shows it stood at 0.51% in 2018, then fell by -21bps to 0.62% in 2019, then plummeted by -69bps to 1.04% in 2020, then crashed by -115bps to 2.24% in 2021, then grew by 29bps to 1.58% in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Return on Capital Employed are 1.58% (Q2 2022), 1.63% (Q1 2022), and 2.24% (Q4 2021).